Cited by 145SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India

Open access
Tyagi, Kanika, Ghosh, Amerta, Nair, Dipti, Dutta, Koel, Singh Bhandari, Prakash, Ahmed Ansari, Irshad, Misra, Anoop·2021·Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Abstract

Background and aims Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility.Methods We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 & RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date.Results Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections > 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease.Conclusions We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dsx.2021.05.001

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Breakthrough infections have emerged in a small percentage of vaccine recipients in other countries and health care institutions.

    “However, breakthrough infections have emerged in a small percentage of vaccine recipients, a phenomenon that has been described in other countries and health care institutions.6-8”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tyagi, K., Ghosh, A., Nair, D., Dutta, K., Singh Bhandari, P., Ahmed Ansari, I., & Misra, A.
Affiliations
  • Fortis C-DOC Hospital (IN)
  • National Diabetes Obesity and Cholesterol Foundation (IN)
Corresponding author
Misra, Anoop
Venue
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Publisher
Elsevier BV
Published
2021-05
Volume
15
Issue
3
Pages
1007-1008
ISSN
1871-4021 (ISSN-L)
OpenAlex
W3159207990
Cited by
145
References
3
Citations by year
2026: 2 · 2025: 3 · 2024: 7 · 2023: 30 · 2022: 56 · 2021: 46
FWCI
11.01
Type
journal article
Language
en
Update notices
erratum (2022-05-01)
Open access
Locations
  • Diabetes & Metabolic Syndrome Clinical Research & Reviews (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords
COVID-19 pandemic, breakthrough infection, COVID-19 vaccination, healthcare workers, Covishield, Covaxin, symptomatic infection, RT-PCR testing, vaccine efficacy
MeSH terms
Immunogenicity, Vaccine, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Breakthrough Infections, Adult, Aged, Female, Follow-Up Studies, Health Facilities, Health Personnel, Humans, India, Male, Middle Aged, Prognosis, Vaccination, Disease Transmission, Infectious, Young Adult, Immune Evasion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review